Related Experiment Video
Updated: Jul 5, 2026
08:12
Killer Artificial Antigen Presenting Cells (KaAPC) for Efficient In Vitro Depletion of Human Antigen-specific T Cells
Published on: August 11, 2014
T cell depletion by cytotoxic elimination.
1National Cancer Institute, Bethesda, Maryland, USA.
Current Protocols in Immunology
|April 25, 2008
Summary
This study details removing T cells from samples using Thy-1 antibodies for cytotoxic elimination. This method effectively isolates T cells and can also fractionate them into subsets using CD markers.
Area of Science:
- Immunology
- Cell Biology
Background:
- T lymphocytes play crucial roles in immune responses.
- Accurate isolation and fractionation of T cells are essential for immunological research.
- Previous methods may lack specificity or be technically demanding.
Purpose of the Study:
- To describe a method for the complete removal of T cells from lymphocyte preparations.
- To outline a protocol for fractionating murine T cells into subpopulations.
- To provide an alternative to existing T cell isolation techniques.
Main Methods:
- Cytotoxic elimination using Thy-1 specific antibodies to remove T cells.
- Utilizing CD-specific antibodies for the removal of T cell subsets.
- Employing a panning procedure for T cell subset enrichment (as an alternative).
Main Results:
- Successful complete removal of T cells from lymphocyte preparations was achieved.
- T cell subsets (CD4+ and CD8+) were effectively removed using CD-specific antibodies.
- The Thy-1 antibody method offers a specific approach to T cell depletion.
Conclusions:
- The described method provides an efficient way to deplete T cells using Thy-1 specific antibodies.
- Fractionation of T cell subsets is feasible via cytotoxic elimination with CD-specific antibodies.
- This technique enhances the ability to study immune cell populations and functions.
Related Concept Videos
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:40Cell-mediated Immune Responses
Overview